🌟 HOPE ON THE HORIZON FOR PANS/PANDAS FAMILIES :star2: - Octapharma has just announced encouraging results from a rigorous Phase III clinical trial of PANZYGA®, an IVIG treatment being studied for its effects on pediatric acute-onset neuropsychiatric syndrome (PANS). - While the primary measure (OCD symptom reduction) did not reach statistical significance, the trial showed clinically meaningful improvement in children’s overall condition, with significant results in the Clinical Global Impression (CGI) — a measure that reflects the full impact of this disease, from behavior and cognition to quality of life. - Kids who received PANZYGA® showed more robust improvement, and notably, those who got the treatment early continued to do better over time. - This gives us something we’ve long needed: a signpost toward progress. - As Dr. Michael Daines shared, this trial offers “a potential therapeutic pathway for families navigating this complex condition.” 🧡 To every parent, caregiver, and clinician walking this road: you are not alone, and science is listening. - 🔗 https://www.prnewswire.com/news-releases/octapharma-releases-results-for-phase-3-superiority-study-of-pediatric-acute-onset-neuropsychiatric-syndrome-302466297.html #PANS #PANDAS #IVIG #PANZYGA #HopeForHealing #NeuroinflammationAwareness #Octapharma #PACEFoundation #ChronicHope #BrainOnFire #MedicalResearchMatters #HealingKids (fb)

We are honored to continue our valued partnership with the Cohasset Triathlon. This marks the third year of our participation as team Look., racing to raise awareness about PANS/PANDAS and help raise vital funds for these brave children and young adults. #CohassetTriathlon #PANS #PANDAS #TeamLook #TriathlonCommunity #RacingForACause #rootcauses #Look (fb)